Literature DB >> 11032736

cDNA representational difference analysis of human neutrophils stimulated by GM-CSF.

S Yousefi1, P R Cooper, B Mueck, S L Potter, G Jarai.   

Abstract

Neutrophils are the first cell type to migrate out of the vascular space and into the inflammatory site during an acute inflammation. However, in chronic inflammatory diseases, such as chronic obstructive pulmonary disease (COPD), a lack of clearance of neutrophils, imbalance between inflammatory mediators produced by neutrophils and their natural inhibitors make these cells a potential cause of tissue destruction in lung disease. Neutrophilic inflammation is generally characterised by high levels of local expression of activating cytokines (e.g., GM-CSF). Only a few studies have been published so far that have investigated the expression of genes preferentially expressed in activated neutrophils. The isolation of such genes, however, can lead to a better understanding of inflammatory disease and the identification of potential novel therapeutic targets or markers of the disease. We performed representational difference analysis of cDNA, a sensitive PCR-based subtractive enrichment procedure, and isolated 12 genes, 1 EST clone, and 3 sequences not represented in the public databases. Differential expression for 9 of these clones was confirmed by Northern hybridisation. Of the above nine transcripts three were chosen and shown to be up-regulated in neutrophils cocultured with stimulated primary human bronchial epithelial cells using a semiquantitative RT-PCR approach. Among the known genes identified were HM-74, CIS1, Cathepsin C, alpha-enolase, CD44, and the gene Translocation Three Four (TTF), most of them previously not known to be involved in GM-CSF induced neutrophil activation. Along with its tissue and cellular distribution we also derived the complete cDNA sequence and genomic structure of CIS1 using an in silico approach. In addition, we also report the initial characterisation of a novel gene, P1-89 that is primarily expressed in granulocytes and is up-regulated in activated cells. Our results identify several important genes associated with neutrophil activation and can lead to a better understanding of the molecular mechanisms of neutrophilic inflammations. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11032736     DOI: 10.1006/bbrc.2000.3678

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Systemic inflammation in COPD visualised by gene profiling in peripheral blood neutrophils.

Authors:  E-J D Oudijk; E H J Nijhuis; M D Zwank; E A van de Graaf; H J Mager; P J Coffer; J-W J Lammers; L Koenderman
Journal:  Thorax       Date:  2005-07       Impact factor: 9.139

Review 2.  Niacin in cardiovascular disease: recent preclinical and clinical developments.

Authors:  Janet E Digby; Neil Ruparelia; Robin P Choudhury
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-12-29       Impact factor: 8.311

3.  Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells.

Authors:  Martina Lukasova; Camille Malaval; Andreas Gille; Jukka Kero; Stefan Offermanns
Journal:  J Clin Invest       Date:  2011-02-07       Impact factor: 14.808

4.  Nicotinic acid- and monomethyl fumarate-induced flushing involves GPR109A expressed by keratinocytes and COX-2-dependent prostanoid formation in mice.

Authors:  Julien Hanson; Andreas Gille; Sabrina Zwykiel; Martina Lukasova; Björn E Clausen; Kashan Ahmed; Sorin Tunaru; Angela Wirth; Stefan Offermanns
Journal:  J Clin Invest       Date:  2010-07-26       Impact factor: 14.808

5.  The haematopoietic GTPase RhoH modulates IL3 signalling through regulation of STAT activity and IL3 receptor expression.

Authors:  Mehtap S Gündogdu; He Liu; Daniela Metzdorf; Dagmar Hildebrand; Michael Aigner; Klaus Aktories; Klaus Heeg; Katharina F Kubatzky
Journal:  Mol Cancer       Date:  2010-08-25       Impact factor: 27.401

Review 6.  Nicotinic acid: an old drug with a promising future.

Authors:  E T Bodor; S Offermanns
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

Review 7.  G protein-coupled receptors for energy metabolites as new therapeutic targets.

Authors:  Clara C Blad; Cong Tang; Stefan Offermanns
Journal:  Nat Rev Drug Discov       Date:  2012-07-13       Impact factor: 84.694

8.  Biological roles and therapeutic potential of hydroxy-carboxylic Acid receptors.

Authors:  Kashan Ahmed
Journal:  Front Endocrinol (Lausanne)       Date:  2011-10-25       Impact factor: 5.555

Review 9.  GPR109A and vascular inflammation.

Authors:  Joshua T Chai; Janet E Digby; Robin P Choudhury
Journal:  Curr Atheroscler Rep       Date:  2013-05       Impact factor: 5.113

10.  The small GTPase RhoH is an atypical regulator of haematopoietic cells.

Authors:  Florian Fueller; Katharina F Kubatzky
Journal:  Cell Commun Signal       Date:  2008-09-29       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.